Cancer regeneration: Polyploid cells are the key drivers of tumor progression

Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188408. doi: 10.1016/j.bbcan.2020.188408. Epub 2020 Aug 20.

Abstract

In spite of significant advancements of therapies for initial eradication of cancers, tumor relapse remains a major challenge. It is for a long time known that polyploid malignant cells are a main source of resistance against chemotherapy and irradiation. However, therapeutic approaches targeting these cells have not been appropriately pursued which could partly be due to the shortage of knowledge on the molecular biology of cell polyploidy. On the other hand, there is a rising trend to appreciate polyploid/ multinucleated cells as key players in tissue regeneration. In this review, we suggest an analogy between the functions of polyploid cells in normal and malignant tissues and discuss the idea that cell polyploidy is an evolutionary conserved source of tissue regeneration also exploited by cancers as a survival factor. In addition, polyploid cells are highlighted as a promising therapeutic target to overcome drug resistance and relapse.

Keywords: Cancer stem cell; Malignancy; Multinucleation; Polyploidy; Regeneration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease Progression
  • Drug Resistance, Neoplasm
  • Evolution, Molecular
  • Humans
  • Neoplasms / genetics*
  • Polyploidy*
  • Regeneration